---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-26-004223"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2026-08-21T20:21:14+00:00"
generated_at: "2026-08-21T20:22:55.475716+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Silexion receives Nasdaq delisting notice for equity shortfall; plans appeal

## Summary
- Nasdaq delisting notice received Aug 18, 2026 for failure to meet $2.5M shareholders' equity requirement (Rule 5550(b)(1)).
- Shareholders' equity as of June 30, 2026 was only $44,000, far below required minimum.
- Company intends to appeal by Aug 25, 2026; under Mandatory Hearings Panel Monitor limiting compliance extensions.
- If appeal fails, ordinary shares and warrants (SLXN, SLXNW) will be suspended and delisted via Form 25-NSE.

## SEC filing metadata
- accession: 0001178913-26-004223
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2026-08-21T20:21:14+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891326004223/0001178913-26-004223-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891326004223/zk2635995.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-26-004223
- JSON: https://secwatch.observer/filing/0001178913-26-004223.json
- Plain text: https://secwatch.observer/filing/0001178913-26-004223.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.